Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$18.9MMiss by $1.5M
EPS-$0.10Miss by $0.09
Revenue estimate$20.5M
EPS estimate-$0.01

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$42.0M
EPS estimate$0.34

Financials

Q2 2025

Income statement

See full
Revenue$18.9M+109%
Gross profit$11.9M+112%
Operating income-$1.5M+49.7%
Net income-$2.6M+15.0%
EPS (diluted)-$0.10+16.7%

Balance sheet

See full
Cash & equivalents$25.4M+43.4%
Total debt$30.7M+529%
Total equity$24.0M+78.0%
Total assets$101.7M+220%

Cash flow

See full
Operating cash flow$8.0M—
CapEx-—
Free cash flow$8.0M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$364.45M+331%
Enterprise value$369.77M+416%
P/S6.3×+3.6×

Profitability

See full
Gross margin59.4%-0.1pp
Net margin-7.1%-2.8pp

Returns & leverage

See full
Return on equity-22.1%-7.4pp
Debt / equity1.3×+0.9×
Current ratio1.8×+0.4×

FAQ

When did Eton Pharmaceuticals, Inc. report Q2 2025 earnings?
Eton Pharmaceuticals, Inc. (ETON) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Eton Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
Eton Pharmaceuticals, Inc. reported revenue of $18.9M and eps of $-0.10 for Q2 2025.
Did Eton Pharmaceuticals, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $20.5M by $1.5M. EPS missed the consensus estimate of $-0.01 by $0.09.
How did Eton Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 108.6% from $9.1M a year earlier and eps grew 16.7% from $-0.12.
Where can I find Eton Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-025438) and the 10-Q periodic report (0001437749-25-025444) directly on SEC EDGAR. The filing index links above go to sec.gov.